NSE - Delayed Quote INR

Lincoln Pharmaceuticals Limited (LINCOLN.NS)

Compare
644.25 -16.55 (-2.50%)
At close: 3:30 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Mahendrabhai Gulabdas Patel B.A, LLB MD & Whole Time Director 4.92M -- 1954
Mr. Darshit Ashvinkumar Shah Chief Financial Officer -- -- --
Ms. Trusha K. Shah Company Secretary & Compliance Officer -- -- --
Mr. Ashish Rajnikant Patel Whole Time Director 6.64M -- 1981
Mr. Hashmukhbhai Ishwarlal Patel B.sc. Whole Time Director 3.81M -- 1958
Mr. Munjal Mahendrabhai Patel Whole Time Director 6.65M -- 1982
Mr. Sanjay Bhatt Senior Manager of Operation -- -- --
Mr. Laxmikant Harsola Vice President of Technical -- -- --
Mr. Sanjiv Patel Senior Manager of Planning & Administration -- -- --
Mr. Amit Dwivedi B-PHARM, MBA Group Marketing Manager -- -- 1976

Lincoln Pharmaceuticals Limited

Lincoln House
Behind Satyam Complex Science City Road Sola
Ahmedabad, 380060
India
91 79 4107 8000 https://www.lincolnpharma.com
Sector:?
Healthcare
Full Time Employees:?
1,687

Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.

Corporate Governance

Lincoln Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 31, 2024 at 10:59 AM UTC - November 4, 2024 at 12:00 PM UTC

Lincoln Pharmaceuticals Limited Earnings Date

Recent Events

September 13, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers